Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
7q21.11 | Developmental and epileptic encephalopathy 110 | 620149 | AR | 3 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
12p13.33 | Brugada syndrome 3 | 611875 | AD | 3 |
Long QT syndrome 8 | 618447 | AD | 3 | |
Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures | 620029 | AD | 3 | |
Timothy syndrome | 601005 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
15q24.1 | {Epilepsy, idiopathic generalized, susceptibility to, 18} | 619521 | AD | 3 |
Brugada syndrome 8 | 613123 | 3 | ||
Sick sinus syndrome 2 | 163800 | AD | 3 |
|
|
|
|
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
1p13.2 | Brugada syndrome 9 | 616399 | AD | 3 |
Spinocerebellar ataxia 19 | 607346 | AD | 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
11q24.1 | Atrial fibrillation, familial, 16 | 613120 | AD | 3 |
Brugada syndrome 7 | 613120 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
11q13.4 | ?Brugada syndrome 6 | 613119 | 3 | KCNE3 | 604433 |
Location | Phenotype | Inheritance |
Phenotype mapping key |
Phenotype MIM number |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
1p13.2 | Brugada syndrome 9 | AD | 3 | 616399 | KCND3 | 605411 |
3p22.3 | Brugada syndrome 2 | AD | 3 | 611777 | GPD1L | 611778 |
3p22.2 | Brugada syndrome 1 | AD | 3 | 601144 | SCN5A | 600163 |
10p12.33-p12.31 | Brugada syndrome 4 | AD | 3 | 611876 | CACNB2 | 600003 |
11q13.4 | ?Brugada syndrome 6 | 3 | 613119 | KCNE3 | 604433 | |
11q24.1 | Brugada syndrome 7 | AD | 3 | 613120 | SCN3B | 608214 |
11q24.1 | Atrial fibrillation, familial, 16 | AD | 3 | 613120 | SCN3B | 608214 |
12p13.33 | Brugada syndrome 3 | AD | 3 | 611875 | CACNA1C | 114205 |
15q24.1 | Brugada syndrome 8 | 3 | 613123 | HCN4 | 605206 | |
19q13.11 | Brugada syndrome 5 | 3 | 612838 | SCN1B | 600235 | |
19q13.11 | Cardiac conduction defect, nonspecific | 3 | 612838 | SCN1B | 600235 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
11q24.1 | Brugada syndrome 7 | 613120 | AD | 3 | SCN3B | 608214 |
11q24.1 | Atrial fibrillation, familial, 16 | 613120 | AD | 3 | SCN3B | 608214 |
Location | Phenotype | Inheritance |
Phenotype mapping key |
Phenotype MIM number |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
1p13.2 | Brugada syndrome 9 | AD | 3 | 616399 | KCND3 | 605411 |
3p22.3 | Brugada syndrome 2 | AD | 3 | 611777 | GPD1L | 611778 |
3p22.2 | Brugada syndrome 1 | AD | 3 | 601144 | SCN5A | 600163 |
10p12.33-p12.31 | Brugada syndrome 4 | AD | 3 | 611876 | CACNB2 | 600003 |
11q13.4 | ?Brugada syndrome 6 | 3 | 613119 | KCNE3 | 604433 | |
11q24.1 | Brugada syndrome 7 | AD | 3 | 613120 | SCN3B | 608214 |
11q24.1 | Atrial fibrillation, familial, 16 | AD | 3 | 613120 | SCN3B | 608214 |
12p13.33 | Brugada syndrome 3 | AD | 3 | 611875 | CACNA1C | 114205 |
15q24.1 | Brugada syndrome 8 | 3 | 613123 | HCN4 | 605206 | |
19q13.11 | Brugada syndrome 5 | 3 | 612838 | SCN1B | 600235 | |
19q13.11 | Cardiac conduction defect, nonspecific | 3 | 612838 | SCN1B | 600235 |
|
|
|
|
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM